AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
agreement with Haisco Pharmaceutical Group for the development of pain medicines. AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development Photo by Pietro Jeng on Pexels Under the terms of the agreement, AbbVie will own the rights to develop, manufacture, and commercialize novel pain treatment compounds globally, excluding China, Hong Kong, and Macau. The program aims to cover multiple compounds that can address various pain-related indications. The compounds are currently under development in various stages in China. They include Nav1.8 inhibitors that block pain signals at the source. The compound spans preclinical through Phase I development in China and is positioned for chronic pain indications. In return, Haisco is to receive $30 million in upfront payment and is also eligible for an additional $715 million in aggregate development, regulatory, and commercial milestone payments. Haisco is also entitled to tiered royalties on future net sales emanating
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus [Yahoo! Finance]Yahoo! Finance
- AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S. [TheStreet.com]TheStreet.com
- Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4 [Yahoo! Finance]Yahoo! Finance
- AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.PR Newswire
- AbbVie (ABBV) was given a new $294.00 price target by Piper Sandler.MarketBeat
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 4/3/26 - Form 8-K
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABBV's page on the SEC website